BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35118731)

  • 1. Inflammatory myofibroblastic tumour of the rectum with a novel anaplastic lymphoma kinase fusion diagnosed on cytology: Not just another submucosal gastrointestinal stromal tumour!
    Logaswari M; Lim KHT; Tan D; Ong CJ; Sittampalam K
    Cytopathology; 2022 May; 33(3):397-401. PubMed ID: 35118731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
    Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
    Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
    Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification.
    Wang K; Guo R; Siegal GP; Wei S
    Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
    Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
    Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous inflammatory myofibroblastic tumor with CARS-ALK fusion: Case report and literature review.
    McCollum KJ; Jour G; Al-Rohil RN
    J Cutan Pathol; 2022 Sep; 49(9):795-801. PubMed ID: 35560368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features of inflammatory myofibroblastic tumor].
    Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
    [No Abstract]   [Full Text] [Related]  

  • 8. Rare presentation of inflammatory myofibroblastic tumor on a digit.
    West CE; Workman A; Moody T; Hosler GA
    J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour.
    Maruggi M; Malicki DM; Levy ML; Crawford JR
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344149
    [No Abstract]   [Full Text] [Related]  

  • 11. An inflammatory myofibroblastic tumour of the breast with ALK overexpression.
    Zhou Y; Zhu J; Zhang Y; Jiang J; Jia M
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23386486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
    Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
    Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.
    Wong HH; Bentley H; Bulusu VR; Anyaegbu G; Watkins J; Horan G; Hatcher H
    Anticancer Drugs; 2020 Nov; 31(10):1106-1110. PubMed ID: 32868646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of anaplastic lymphoma kinase expression in deep soft tissue calcifying fibrous pseudotumor: evidence of a late sclerosing stage of inflammatory myofibroblastic tumor?
    Sigel JE; Smith TA; Reith JD; Goldblum JR
    Ann Diagn Pathol; 2001 Feb; 5(1):10-4. PubMed ID: 11172201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
    Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G
    Eur J Cancer; 2021 Nov; 157():198-213. PubMed ID: 34536944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel ALK-THBS1 Fusion in a Laryngeal Inflammatory Myofibroblastic Tumour: A Case Report and Literature Review.
    Elktaibi A; Benzerdjeb N; Ameur F; Daveau C; Tantot J; Costes Martineau V
    Head Neck Pathol; 2020 Jun; 14(2):454-458. PubMed ID: 31368077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
    Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
    Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.